Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EMERGENT BIOSOLUTIONS INC.

(EBS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Janssen COVID-19 vaccine plant in Baltimore gets Health Canada OK

11/24/2021 | 11:28am EST

OTTAWAHealth Canada has given the green light for Johnson & Johnson COVID-19 vaccines that contained elements produced at the Emergent BioSolutions facility in Baltimore, Md., to be used in Canada, though no shipments are currently planned.

Canada had rejected hundreds of thousands of doses of the vaccine this past summer due to contamination concerns about the plant, and only imported Johnson & Johnson doses, also known as Janssen, manufactured in Europe.

After an on-site inspection of the facility, the regulator has now deemed the facility to be compliant with the necessary quality-assurance practices.

That means Janssen will now be able to import COVID-19 vaccines into Canada that contain drugs manufactured at the Emergent BioSolutions facility.

According to Health Canada, there are no further shipments of the Janssen vaccine planned for now, though the government will work with provinces and territories if they require more supply.

The European Medicines Agency and South African Health Products Regulatory Authority also participated in this inspection remotely and agreed with Canada's assessment of the facility.

This report by The Canadian Press was first published Nov. 24, 2021.

© 2021 The Canadian Press. All rights reserved., source Canadian Press DataFile

Stocks mentioned in the article
ChangeLast1st jan.
EMERGENT BIOSOLUTIONS INC. 5.54% 52.22 End-of-day quote.20.13%
JOHNSON & JOHNSON -0.55% 167.84 End-of-day quote.-1.89%
All news about EMERGENT BIOSOLUTIONS INC.
01/14EMERGENT BIOSOLUTIONS INC. : Change in Directors or Principal Officers, Regulation FD Disc..
AQ
01/14Emergent Biosolutions Chairman to Retire in April
MT
01/14Founder and Executive Chairman of Emergent BioSolutions Announces Retirement
AQ
01/14Emergent BioSolutions Inc. Announces Retirement of Fuad El-Hibri, Founder and Executive..
CI
01/10Emergent BioSolutions to Look for M&A
CI
01/10EMERGENT BIOSOLUTIONS : Announces 2022 Financial Guidance, Provides Preliminary 2021 Resul..
PU
01/10EMERGENT BIOSOLUTIONS INC. : Results of Operations and Financial Condition, Regulation FD ..
AQ
01/10Emergent Biosolutions Reports Preliminary 2021 Adjusted Net Income, Revenue In Line Wit..
MT
01/09Emergent BioSolutions Announces 2022 Financial Guidance, Provides Preliminary 2021 Resu..
AQ
01/09Emergent BioSolutions Inc. Provides Earnings Guidance for the Full Year 2022
CI
More news
Analyst Recommendations on EMERGENT BIOSOLUTIONS INC.
More recommendations
Financials (USD)
Sales 2021 1 722 M - -
Net income 2021 255 M - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 2 809 M 2 809 M -
Capi. / Sales 2021 1,63x
EV / Sales 2022 1,95x
Nbr of Employees 2 200
Free-Float 88,6%
Chart EMERGENT BIOSOLUTIONS INC.
Duration : Period :
Emergent BioSolutions Inc. Technical Analysis Chart | EBS | US29089Q1058 | MarketScreener
Technical analysis trends EMERGENT BIOSOLUTIONS INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 52,22 $
Average target price 57,40 $
Spread / Average Target 9,92%
EPS Revisions
Managers and Directors
Robert G. Kramer President, Chief Executive Officer & Director
Richard Scott Lindahl Chief Financial Officer, Treasurer & Executive VP
Fuad El Hibri Executive Chairman
Sharon M. Solomon Chief Information Officer & Senior Vice President
Christopher H. Cabell Head-Clinical Development
Sector and Competitors
1st jan.Capi. (M$)
EMERGENT BIOSOLUTIONS INC.20.13%2 809
JOHNSON & JOHNSON-1.89%441 855
ROCHE HOLDING AG-3.72%323 901
PFIZER, INC.-6.94%308 427
ABBVIE INC.0.35%240 202
ELI LILLY AND COMPANY-11.62%221 317